VIROGATES

ViroGates is an international Medtech company headquartered North of Copenhagen, in the heart of Medicon Valley... Inventor and co-founder Jesper Eugen-Olsen initially discovered the utility of the biomarker suPAR in HIV. More than 900 publications have followed, substantiating suPAR as one of the most promising prognostic biomarkers across diseases. ViroGates has developed a patented product line called suPARnostic® to make the suPAR test commercially available... We improve patient outcomes and reduce healthcare costs. Biomarker suPAR in triage predicts critical illness across diseases.

Also known as: ViroGates A/S

Registration numbers: 25734033 (W)

VAT numbers: DK-25734033

Primary location: Denmark